HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.395
-0.005 (-1.28%)
Apr 29, 2026, 11:55 AM EDT - Market open
HCW Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 1.95 | 4.67 | 3.6 | 22.33 | 11.73 | Upgrade
|
| Short-Term Investments | - | - | - | 9.74 | 24.98 | Upgrade
|
| Cash & Short-Term Investments | 1.95 | 4.67 | 3.6 | 32.06 | 36.71 | Upgrade
|
| Cash Growth | -58.23% | 30.03% | -88.79% | -12.67% | 334.19% | Upgrade
|
| Accounts Receivable | 0.03 | 0.58 | 1.54 | 0.42 | - | Upgrade
|
| Other Receivables | - | - | - | - | 0.13 | Upgrade
|
| Receivables | 0.03 | 0.58 | 1.54 | 0.42 | 0.13 | Upgrade
|
| Prepaid Expenses | 0.22 | 0.33 | 1.04 | 1.39 | 2.2 | Upgrade
|
| Other Current Assets | 0.08 | 0.11 | 0.23 | 0.2 | 1.44 | Upgrade
|
| Total Current Assets | 2.28 | 5.7 | 6.4 | 34.07 | 40.48 | Upgrade
|
| Property, Plant & Equipment | 20.88 | 22.91 | 20.45 | 10.8 | 1.12 | Upgrade
|
| Long-Term Investments | 1.33 | 1.6 | 1.6 | 1.6 | 11.52 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.06 | 0.33 | 0.39 | Upgrade
|
| Total Assets | 24.52 | 30.24 | 28.51 | 46.81 | 53.51 | Upgrade
|
| Accounts Payable | 13.14 | 22.33 | 6.17 | 1.23 | 0.22 | Upgrade
|
| Accrued Expenses | 1.1 | 0.95 | 2.43 | 1.55 | 0.3 | Upgrade
|
| Short-Term Debt | 6.81 | 6.31 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.12 | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.03 | 0.18 | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.8 | Upgrade
|
| Other Current Liabilities | 0.01 | 0.03 | - | - | - | Upgrade
|
| Total Current Liabilities | 21.06 | 29.63 | 8.75 | 2.96 | 2.32 | Upgrade
|
| Long-Term Debt | - | 7.38 | 6.3 | 6.41 | - | Upgrade
|
| Long-Term Leases | - | - | - | 0.01 | - | Upgrade
|
| Other Long-Term Liabilities | 0.69 | - | - | - | - | Upgrade
|
| Total Liabilities | 21.76 | 37.01 | 15.05 | 9.38 | 2.32 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 111.28 | 93.79 | 83.99 | 82.96 | 81.83 | Upgrade
|
| Retained Earnings | -108.52 | -100.56 | -70.53 | -45.54 | -30.64 | Upgrade
|
| Total Common Equity | 2.76 | -6.77 | 13.46 | 37.43 | 51.19 | Upgrade
|
| Shareholders' Equity | 2.76 | -6.77 | 13.46 | 37.43 | 51.19 | Upgrade
|
| Total Liabilities & Equity | 24.52 | 30.24 | 28.51 | 46.81 | 53.51 | Upgrade
|
| Total Debt | 6.81 | 13.69 | 6.45 | 6.6 | - | Upgrade
|
| Net Cash (Debt) | -4.86 | -9.02 | -2.86 | 25.46 | 36.71 | Upgrade
|
| Net Cash Growth | - | - | - | -30.65% | 365.41% | Upgrade
|
| Net Cash Per Share | -2.32 | -9.30 | -3.18 | 28.43 | 78.24 | Upgrade
|
| Filing Date Shares Outstanding | 6.73 | 1.12 | 0.95 | 0.9 | 0.89 | Upgrade
|
| Total Common Shares Outstanding | 3.28 | 1.11 | 0.9 | 0.9 | 0.89 | Upgrade
|
| Working Capital | -18.78 | -23.93 | -2.34 | 31.11 | 38.16 | Upgrade
|
| Book Value Per Share | 0.84 | -6.08 | 14.95 | 41.73 | 57.25 | Upgrade
|
| Tangible Book Value | 2.76 | -6.77 | 13.46 | 37.43 | 51.19 | Upgrade
|
| Tangible Book Value Per Share | 0.84 | -6.08 | 14.95 | 41.73 | 57.25 | Upgrade
|
| Land | 2.15 | 2.15 | 2.15 | 2.15 | - | Upgrade
|
| Buildings | 6.11 | 6.11 | 6.11 | 6.11 | - | Upgrade
|
| Machinery | 2.66 | 2.66 | 2.66 | 2.62 | 2.42 | Upgrade
|
| Construction In Progress | 12.02 | 13.55 | 10.44 | 0.05 | - | Upgrade
|
| Leasehold Improvements | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.